- Home
- RPHM vs NXN Comparison
RPHM vs NXN Comparison
Compare RPHM & NXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPHM
- NXN
- Stock Information
- Founded
- RPHM 2014
- NXN 1992
- Country
- RPHM United States
- NXN United States
- Employees
- RPHM N/A
- NXN N/A
- Industry
- RPHM Biotechnology: Pharmaceutical Preparations
- NXN Trusts Except Educational Religious and Charitable
- Sector
- RPHM Health Care
- NXN Finance
- Exchange
- RPHM Nasdaq
- NXN Nasdaq
- Market Cap
- RPHM 47.5M
- NXN 47.4M
- IPO Year
- RPHM 2021
- NXN N/A
- Fundamental
- Price
- RPHM $18.20
- NXN $12.15
- Analyst Decision
- RPHM Hold
- NXN
- Analyst Count
- RPHM 6
- NXN 0
- Target Price
- RPHM $2.26
- NXN N/A
- AVG Volume (30 Days)
- RPHM 345.4K
- NXN 9.7K
- Earning Date
- RPHM 11-11-2024
- NXN 01-01-0001
- Dividend Yield
- RPHM N/A
- NXN 4.23%
- EPS Growth
- RPHM N/A
- NXN N/A
- EPS
- RPHM N/A
- NXN 0.24
- Revenue
- RPHM N/A
- NXN N/A
- Revenue This Year
- RPHM N/A
- NXN N/A
- Revenue Next Year
- RPHM N/A
- NXN N/A
- P/E Ratio
- RPHM N/A
- NXN $48.42
- Revenue Growth
- RPHM N/A
- NXN N/A
- 52 Week Low
- RPHM $1.68
- NXN $10.64
- 52 Week High
- RPHM $92.10
- NXN $12.45
- Technical
- Relative Strength Index (RSI)
- RPHM 18.64
- NXN 60.72
- Support Level
- RPHM $16.10
- NXN $12.02
- Resistance Level
- RPHM $19.00
- NXN $12.13
- Average True Range (ATR)
- RPHM 1.09
- NXN 0.13
- MACD
- RPHM -1.48
- NXN -0.01
- Stochastic Oscillator
- RPHM 0.00
- NXN 35.95
About RPHM Reneo Pharmaceuticals Inc.
Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.